CAMBRIDGE, United Kingdom and BOSTON, Feb. 20, 2017 /PRNewswire/ -- Clinical NLP provider Linguamatics, and Varian Medical Systems, today announced that Varian will utilize Linguamatics' natural language processing (NLP) technology as part of the data analytics within Varian's 360 Oncology™ care management platform.
Varian 360 Oncology care management is a software solution designed to meet the full spectrum of needs in oncology care management for hospitals and cancer centres at the oncology department level. It is capable of tracking physician and cancer specialist referrals, integrating evidence, outcomes data, guidelines and care pathways, coordinating data from multiple sites and settings including patients and external caregivers. Varian will utilize the Linguamatics Health platform, powered by Linguamatics I2E text mining technology, to extract unstructured concepts from within pathology reports and convert them to discrete data elements for analytics reporting within Varian 360 Oncology.
"We chose to work with Linguamatics because of their experience in mining oncology data to improve clinical reporting and patient outcomes," said Rachan Rao, Director Software Support Services, Varian Medical Systems. "The use of NLP to extract key clinical concepts from patient documentation such as pathology, radiology and progress notes, provides oncology specialists with a more comprehensive view of their patients' conditions and facilitates the creation of care management plans that are more precisely tailored to each individual patient based on their health status."
"Varian has a rich history of delivering innovative, state-of-the-art cancer-fighting solutions and is dedicated to its goal of realizing a world without the fear of cancer," said Simon Beaulah, Senior Director of Healthcare, Linguamatics. "Like Varian, Linguamatics is committed to leveraging clinical information so that care is improved for every patient to achieve optimal outcomes. We look forward to working with Varian and further advancing the fight against cancer."
To learn more about the Linguamatics and Varian relationship, please visit Linguamatics (booth 4944) or Varian (booth 8067) at the HIMSS17 Conference and Expo, February 19-23 in Orlando.
About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people at sites around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
About Linguamatics
Linguamatics transforms unstructured big data into big insights to advance human health and wellbeing. A world leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support, Linguamatics' solutions are used by top commercial, academic and government organizations, including 17 of the top 20 global pharmaceutical companies, the US Food and Drug Administration (FDA) and US National Cancer Institute, Cancer Research UK, and leading US healthcare organizations. Linguamatics I2E is used to mine a wide variety of text resources, such as scientific literature, patents, Electronic Health Records (EHRs), clinical trials data, news feeds, social media and proprietary content. I2E can be deployed as an in-house enterprise system, or as Software-as-a-Service (SaaS) on the cloud. For more information, visit linguamatics.com and follow @Linguamatics on Twitter.
Linguamatics Media contact:
Michelle Ronan Noteboom, Sr. Account Director
Amendola Communications
+ 1 512.426.2870
mnoteboom@acmarketingpr.com
Varian Medical Systems Media contact:
Mark Plungy, Director of PR
Varian Medical Systems
+ 1 650.424.5630
mark.plungy@varian.com
SOURCE Linguamatics
